Lausanne, Switzerland
Xsensio, a Swiss digital health company founded in 2017, is pioneering advancements in healthcare monitoring with its Lab-on-Skin™ wearable sensing platform. This cutting-edge technology provides real-time biochemical information at the skin's surface, unlocking data never explored before. Catering to the B2B market, Xsensio partners with entities seeking innovative solutions for remote patient monitoring both at home and in hospital settings.
The company's operations span across multiple industries including Analytics, Hardware, Health Care, Autonomous and Sensor Tech, and Machine Learning, with its headquarters stationed in Switzerland.
In a recent Series A funding round concluded on March 3, 2026, Xsensio raised €7.00M, backed by notable investors such as Privilège Ventures, the European Innovation Council, WI Harper, and a range of private investors from the United States, Europe, and Asia. This investment underscores a strong belief in the potential and future growth trajectory of Xsensio in the healthcare space.
